Number of pages: 100 | Report Format: PDF | Published date: 23 May, 2022
Historical Years – 2018 & 2019 | Base Year – 2020 | Forecasted Years – 2021-2031
The global HbA1c testing market was pegged at US$ 1.3 billion in 2020 and is expected to witness a CAGR of 8.5% during the forecast period.
HbA1c test is also known as the glycated haemoglobin or haemoglobin A1c test. Measuring glycated haemoglobin (HbA1c) gives an overall picture of average blood sugar levels of a person over past three months. The test is used in detection of diabetes or prediabetes in adults. High HbA1c levels can be a sign of diabetes, a chronic condition that can cause serious health problems such as heart disease, nerve damage, and kidney disease. This test can also help in monitoring a person's glucose levels. A normal A1C level is below 5.7 percent.
The global HbA1c testing market is mainly driven by the rising prevalence of diabetes, rising geriatric population, and increasing awareness on diabetes management. Moreover, factors such as low test cost, technological advancements, and FDA-approved product launches are playing a pivotal role to propel the HbA1c testing market growth. However, certain factors such as genetic variants, modified derivatives of hemoglobin can affect the accuracy of HbA1c and likely to hinder adoption of HbA1c test to a certain extent.
The global HbA1c testing market has been analyzed from four perspectives: Product, Technology, End User, and Region.
HbA1c Testing Market by Product
Based on product, the HbA1c testing market has been segmented into instruments and consumables. Instruments segment is further divided into benchtop device and handheld device. Instruments segment held the largest share of the total market in 2020. The rising prevalence of diabetes and ability to get faster and accurate results are some of the factors driving the growth of this segment.
HbA1c Testing Market by Technology
Based on technology, the market has been segmented into ion-exchange HPLC, boronate affinity chromatography, turbidimetric inhibition immunoassay, direct enzymatic assay, and other technologies. Ion-exchange HPLC segment held the largest market share of the HbA1c testing market. Greater accuracy, sensitivity, and low cost are some of the advantages of using ion-exchange HPLC for measuring HbA1c testing. These advantages are driving the use of this technology.
HbA1c Testing Market by End User
Based on end user, the market has been segmented into hospitals & clinics, diagnostic laboratories, and home care. Home care segment is anticipated to be the fastest growing segment during the forecast period. Rising awareness and adoption of diabetes self-management is one of the major factors expected to fuel the growth of this segment.
HbA1c testing Market by Region
Regionally, the global HbA1c testing market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America held the largest share of the global HbA1c testing market. Rising geriatric population suffering from diabetes coupled with the growing need for continuous glucose level monitoring among diabetes patients are among the major factors boosting the HbA1c testing market growth. Moreover, factors such as the presence of large number of laboratories providing HbA1c testing services and the prominent players focused on launching new products in this region are also propelling the growth of this market.
Some of the prominent players operating in the global HbA1c testing market include Abbott, Siemens Healthcare Private Limited, Arkray, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., PTS Diagnostics, Transasia Bio-Medicals, Danaher, Trinity Biotech, and Tosoh Corporation, among others.